Does Rallies show Form 4 insider transactions for RBOT?

Yes. Rallies tracks RBOT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is RBOT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RBOT. It does not provide personalized investment advice.

RBOT (Vicarious Surgical Inc.) Stock Analysis - Insider Trades

Vicarious Surgical Inc. (RBOT) is a publicly traded Healthcare sector company. As of May 21, 2026, RBOT trades at $1.92 with a market cap of $13.67M and a P/E ratio of 0.00. RBOT moved -3.52% today. Year to date, RBOT is -80.05%; over the trailing twelve months it is -96.02%. Its 52-week range spans $0.27 to $19.00. Analyst consensus is hold with an average price target of $8.75. Rallies surfaces RBOT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RBOT stock inside the company?

Recent RBOT insider activity includes Sachs Adam David sold 942, Khalifa Sammy sold 754, Sachs Adam David sold 463, Khalifa Sammy sold 239, and Khalifa Sammy sold 653. Rallies tracks insider transaction dates, shares, prices, and estimated values.

RBOT Key Metrics

Key financial metrics for RBOT
Metric	Value
Price	$1.92
Market Cap	$13.67M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$19.00
52-Week Low	$0.27
Volume	53.79K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-63.22M
Gross Margin	0.00%

Recent RBOT Insider Trades

Sachs Adam David sold 942 (~$1.97K) on Feb 20, 2026.
Khalifa Sammy sold 754 (~$1.57K) on Feb 20, 2026.
Sachs Adam David sold 463 (~$1.37K) on Dec 3, 2025.
Khalifa Sammy sold 239 (~$709.83) on Dec 3, 2025.
Khalifa Sammy sold 653 (~$1.79K) on Nov 20, 2025.

Latest RBOT News

Vicarious Surgical Faces NYSE Delisting After Market Cap Drops Below $15M — Mar 4, 2026
Vicarious Surgical Taps Global Engineering Partner to Lower Cash Burn and Speed Development — Dec 30, 2025

RBOT Analyst Consensus

5 analysts cover RBOT: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $8.75.

Common questions about RBOT

Who is trading RBOT stock inside the company?: Recent RBOT insider activity includes Sachs Adam David sold 942, Khalifa Sammy sold 754, Sachs Adam David sold 463, Khalifa Sammy sold 239, and Khalifa Sammy sold 653. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RBOT?: Yes. Rallies tracks RBOT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RBOT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RBOT. It does not provide personalized investment advice.